The most common mutant of EGFR in GBM is EGFRvIII, expressed in 31% of patients [33], and overexpression or amplification of EGFR is a feature of aggressive primary GBM and associated with tumour infiltration [34]. This evidence concerns the gene EGFR and neoplasm.